FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a conjugate containing a sulfonamide of formula (I) and an analogue of human insulin. The following is also provided: a pharmaceutical composition containing a conjugate for treating a disease, for example, gestational diabetes, type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia and/or for reducing blood glucose levels.
EFFECT: obtaining insulin conjugates.
15 cl, 8 dwg, 9 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INSULIN ANALOGUES CHARACTERIZED BY REDUCED AFFINITY OF BINDING TO INSULIN RECEPTORS | 2019 |
|
RU2816595C2 |
| BINDER FOR PEPTIDES | 2019 |
|
RU2808687C2 |
| INSULIN AND ITS DERIVATIVES WITH ENHANCED CAPACITY TO BIND ZINC | 1997 |
|
RU2176646C2 |
| SULFOMALEIMIDE-BASED LINKERS AND CORRESPONDING CONJUGATES | 2019 |
|
RU2815199C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING INSULIN AND GLUCAGON | 2019 |
|
RU2823246C2 |
| NEW ANALOGS OF INSULIN OF INCREASED ZINCBINDING | 1999 |
|
RU2225723C2 |
| INSULIN ANALOGUE COMPLEX WITH REDUCED AFFINITY TO INSULIN RECEPTOR AND ITS USE | 2018 |
|
RU2779462C2 |
| ANTIBODY-DRUG CONJUGATES BASED ON ERIBULIN AND APPLICATION METHODS | 2017 |
|
RU2754369C2 |
| PORCINE TRYPSIN OPTIONS | 2019 |
|
RU2783315C2 |
| HUMAN INSULIN ANALOGS, METHOD OF THEIR SYNTHESIS, INJECTION SOLUTION | 1986 |
|
RU2104305C1 |
